Leishmania amazonensis Arginase Compartmentalization in the Glycosome Is Important for Parasite Infectivity by Silva, Maria Fernanda Laranjeira da et al.
  Universidade de São Paulo
 
2012
 
Leishmania amazonensis Arginase
Compartmentalization in the Glycosome Is
Important for Parasite Infectivity
 
 
PLOS ONE, SAN FRANCISCO, v. 7, n. 3, supl. 1, Part 2, pp. 336-365, 11018, 2012
http://www.producao.usp.br/handle/BDPI/37983
 
Downloaded from: Biblioteca Digital da Produção Intelectual - BDPI, Universidade de São Paulo
Biblioteca Digital da Produção Intelectual - BDPI
Departamento de Fisiologia - IB/BIF Artigos e Materiais de Revistas Científicas - IB/BIF
Leishmania amazonensis Arginase
Compartmentalization in the Glycosome Is Important for
Parasite Infectivity
Maria Fernanda Laranjeira da Silva1, Ricardo Andrade Zampieri1, Sandra M. Muxel1,
Stephen M. Beverley2, Lucile M. Floeter-Winter1*
1Departamento de Fisiologia, Instituto de Biocieˆncias, Universidade de Sa˜o Paulo, Sa˜o Paulo, Sa˜o Paulo, Brazil, 2Department of Molecular Microbiology, Washington
University School of Medicine, St. Louis, Missouri, United States of America
Abstract
In Leishmania, de novo polyamine synthesis is initiated by the cleavage of L-arginine to urea and L-ornithine by the action of
arginase (ARG, E.C. 3.5.3.1). Previous studies in L. major and L. mexicana showed that ARG is essential for in vitro growth in
the absence of polyamines and needed for full infectivity in animal infections. The ARG protein is normally found within the
parasite glycosome, and here we examined whether this localization is required for survival and infectivity. First, the
localization of L. amazonensis ARG in the glycosome was confirmed in both the promastigote and amastigote stages. As in
other species, arg2 L. amazonensis required putrescine for growth and presented an attenuated infectivity. Restoration of a
wild type ARG to the arg2 mutant restored ARG expression, growth and infectivity. In contrast, restoration of a cytosol-
targeted ARG lacking the glycosomal SKL targeting sequence (argDSKL) restored growth but failed to restore infectivity.
Further study showed that the ARGDSKL protein was found in the cytosol as expected, but at very low levels. Our results
indicate that the proper compartmentalization of L. amazonensis arginase in the glycosome is important for enzyme activity
and optimal infectivity. Our conjecture is that parasite arginase participates in a complex equilibrium that defines the fate of
L-arginine and that its proper subcellular location may be essential for this physiological orchestration.
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Introduction
Leishmaniasis is the second most important infection caused by
a protozoan and affects 12 million people worldwide (WHO).
Considered to be one of the most neglected tropical diseases,
leishmaniasis is endemic in almost all tropical and subtropical
areas and causes a wide range of devastating and potentially
deadly diseases. There is no vaccine to prevent leishmaniasis, and
the drug arsenal to treat this disease presents many problems,
including toxicity and increasing parasite resistance to common
chemotherapies. Therefore, the study and validation of new drug
targets are important for the development of effective chemother-
apies.
The causative agents of leishmaniasis are protozoan parasites of
the genus Leishmania, family Trypanosomatidae. The life cycle of
Leishmania includes the extracellular promastigote form that resides
in the midgut of the phlebotomine sand fly vector. The obligate
intracellular amastigote form inhabits the phagolysosomes of
mononuclear phagocytes (mainly macrophages) within the mam-
malian host. Leishmania is able to survive and replicate in these
different environments by adapting to a wide range of tempera-
tures, pH levels and nutrient availability and also by escaping the
anti-proliferative defense molecules produced by the host cell
[1,2].
The amino acid L-arginine appears to play a key role in the
survival of Leishmania in the mammalian host [3–5]. The
modulation of the Th1/Th2 balance can induce either the death
or proliferation of intracellular Leishmania in the macrophages [6–
8], and L-arginine plays an important role in this process as a
common substrate of the inducible nitric oxide synthase (iNOS)
and the ARG of the host [9]. These enzymes are competitively
regulated by type 1 (Th1) and type 2 (Th2) cytokines, with
increased iNOS and decreased ARG levels contributing to parasite
control in Th1 responses, and decreased iNOS and increased
ARG levels contributing to parasite survival in Th2 responses.
Host cell metabolism of L-arginine is further complicated by the
fact that Leishmania parasites also express a highly active uptake
pathway for arginine and their own ARG. L. amazonensis [10] and
L. mexicana [11] ARG proteins and enzyme activities have been
biochemically characterized, as have their coding genes. Charac-
terization of mutant parasites lacking ARG (arg2) in L. mexicana and
L. major demonstrated that the ARG pathway is essential for in vitro
proliferation of these parasites, rendering arg2 parasites auxotro-
phic for polyamines [11,12]. The L. mexicana arg2 parasites showed
attenuated infectivity in BALB/c mice, which was attributed to an
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increase in host nitric oxide (NO) production due to L-arginine
availability [13]. In contrast, the L. major arg2-attenuated infectivity
in BALB/c mice was not due to NO overproduction. Moreover,
the cytokine profile response induced by L. major arg2 was not
different from that induced by WT parasites, suggesting that the
effect of ARG on L. major infection is not associated with the host
immune response [14].
Previously, using L. amazonensis promastigotes expressing a
glycosomal-targeted EGFP (enhanced green fluorescent protein),
we showed that ARG is compartmentalized in glycosomes by co-
localizing glycosomal EGFP with ARG immunolabeling [15].
Glycosomes are peroxisome-like organelles, unique to trypanoso-
matids, where a part of carbohydrate metabolism is compartmen-
talized [16,17]. Another strategy revealed the same location for L.
mexicana promastigote ARG using ARG fused to EGFP, which co-
localized with a glycosomal marker [11]. These authors suggested
that the glycosomal milieu is not essential for the role of ARG in
polyamine biosynthesis [11]. The maintenance and importance of
ARG glycosomal compartmentalization, however, was not further
verified during parasite infection in vitro or in vivo. Here, after
confirming that ARG remains in the glycosome during macro-
phage infection, we show that both the incorrect localization and
the lack of ARG impair parasite proliferation and attenuate
infection. The results of this study indicate that the proper sub-
cellular compartmentalization of L. amazonensis ARG in the
glycosome is important for enzyme activity and proper physiolog-
ical functioning during parasite infection.
Results
L. amazonensis ARG remains in the glycosome in the
amastigote form during macrophage infection
Infected J774A 1 macrophages were probed with anti-ARG
polyclonal antibodies to determine ARG localization in the L.
amazonensis amastigote form by electron microscopy (EM)
immunolocalization experiments (Figure 1A). As a control, ARG
immunolabeling was also performed with promastigotes
(Figure 1B). These experiments revealed that the enzyme remains
compartmentalized in a membrane-surrounded compartment,
assumed to be the glycosome given its resemblance to the
promastigote labeling pattern.
Generation of an ARG-null mutant of L. amazonensis
(arg2) and complemented lines bearing WT or a
glycosomal targeting sequence deleted ARG (argDSKL)
To study the role of L. amazonensis ARG during the parasite life
cycle, an ARG null mutant (arg2) was generated by homologous
gene replacement (Figure S1A). As Leishmania do not undergo
sexual recombination when grown in vitro [18], two successive
rounds of targeting are required because Leishmania is disomic at
most chromosomes [19]. The 59 and 39 untranslated coding
regions (UTR) flanking the ARG open reading frame (ORF) were
joined to fragments expressing resistance to Hygromycin B (HYG)
or Puromycin (PAC) as described in the Methods Section. These
targeting constructs were then introduced successively into WT L.
amazonensis, ultimately yielding the homozygous knockout DAR-
G:HYG/DARG:PAC, referred to hereafter as arg2. Loss of ARG and
generation of the planned replacements for both ARG alleles were
confirmed by PCR (Figure S1B).
To restore ARG expression and to evaluate how its cellular
location affects its physiological role in L. amazonensis, both WT
and a modified ARG ORF lacking the C-terminal SKL glycosomal
targeting sequence were stably integrated into the SSU rRNA
locus of the arg2 mutant, yielding lines referred as arg2/+ARG and
arg2/+argDSKL, respectively (Figure S2A). Successful introduction
of the ARG ORF and integration into the SSU rRNA locus were
confirmed by PCR analyses (Figure S2B).
Characterization of arg2 and arg2/+ARG and arg2/
+argDSKL
The level of ARG mRNA expression was quantified by real-
time PCR, normalized to the expression of GAPDH (Figure 2A).
As expected, ARG mRNA expression was abolished in the arg-
parasites. The add-back mutants arg2/+ARG and arg2/
+argDSKL showed substantial restoration of ARG mRNA
expression (60% and 50%, respectively; Figure 2A). Treatment
of WT and add-back parasites with Sinefungin and Actinomycin
to completely inhibit mRNA synthesis [20] showed that the
mRNA half-lives of the ARGs integrated into SSU rRNA locus
are less than the WT ARG mRNA half-life (Text S1, Figure S3).
Enzymatic assays similarly revealed that the arg2 parasite lacked
detectable ARG activity. Similar to the mRNA results, the arg2/
+ARG add-back showed partial rescue of ARG activity
(29.7 nmol/min/mg) to approximately 15% of the WT ARG
activity (191.1 nmol/min/mg). In contrast, the arg2/+argDSKL
mutant did not show any detectable ARG activity (Figure 2B).
Western blot analysis using anti-ARG sera confirmed the
complete absence of ARG in arg2 and the lowered levels of ARG
in the partially rescued arg2/+ARG mutant parasites, to approx-
imately 65% of the WT (Figure 2C and S4A; in these studies,
reactivity with an anti-Orc1 antiserum was used as a loading
control). Corroborating the ARG activity result, a weak labeling
was observed in the arg2/+argDSKL mutants.
ARG immunolabeling by EM settled that the enzyme was
compartmentalized in the glycosome in arg2/+ARG parasites.
Most importantly, EM study in arg2/+argDSKL parasites showed
that ARG was distributed throughout the cell cytosol, not
compartmentalized, which confirms the incorrect targeting of
ARG in arg2/+argDSKL (Figure 3).
Seeking conditions that would allow the detection of argDSKL,
all parasites were treated with MG-132 (carbobenzoxy-L-leucyl-L-
leucyl-leucinal), an inhibitor of proteasome activity. This approach
resulted in a time-dependent ARG accumulation that enabled
ARG detection in the arg2/+argDSKL mutant. After 24 hours
with MG-132, arg2/+argDSKL labeling increased approximately
34%, which still corresponded to approximately 5% of the WT
ARG levels submitted to the same treatment (Figure 2C and S4B).
ARG accumulation in WT and arg2/+ARG parasites was 40 and
45%, respectively, and the arg2/+ARG ARG level was approxi-
mately 60% of the WT ARG level.
Treatment with MG-132 also enabled ARG to be localized in
the add-back mutants by confocal immunofluorescence (Figure
S5). These images confirmed the ARG accumulation after MG-
132 treatment in WT and add-back mutants and also showed that
ARG was not compartmentalized in arg2/+argDSKL parasites, as
was observed in the WT and arg2/+ARG parasites, but was instead
distributed throughout the cell cytosol, corroborating the incorrect
targeting of ARG in arg2/+argDSKL.
L-arginine cellular concentration is modulated by ARG
expression
L-arginine intracellular concentration was determined in WT
and mutant parasites by HPLC analysis (Table 1). L-arginine
levels in arg2 parasites increased four-fold over WT (79626 vs.
1960.4 nmol/107 parasites; p,0.05), while the level in the arg2/
+ARG add-back parasites was not significantly different from that
in WT parasites (29614 nmol/107 parasites). In contrast, the L-
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Figure 1. L. amazonensis ARG remains compartmentalized during macrophage in vitro infection. Cytological preparation probed for
arginase immunolocalization via electron microscopy. (A) J774A 1 macrophages infected for 24 hours with L. amazonensis promastigotes in the
stationary phase (4 different sections). (B) L. amazonensis promastigotes. Black arrows indicate compartmentalized ARG labeling. Parasite nuclei (N),
macrophage nuclei (MN) and the kinetoplast (K) are indicated. Scale bar: 200 nm.
doi:10.1371/journal.pone.0034022.g001
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arginine pool was significantly increased in the arg2/+argDSKL
parasites (94627 nmol/107 parasites), comparable with that
observed in the arg2 parasites. The cellular concentration of other
amino acids did not differ between WT parasites and any of the
mutant parasites (data not shown). These results indicate that
proper ARG localization and activity is important for the
maintenance of L-arginine levels in Leishmania.
ARG activity is important for parasite growth, despite
sub-cellular location
To determine the importance of ARG levels and sub-cellular
location for parasite proliferation, the growth of arg2 and the
genetically complemented parasites, with or without putrescine
supplementation, were evaluated. These experiments were
performed using M199 medium with reduced levels of fetal
bovine serum (FBS, 0.5% rather than 10%) to minimize the effects
arising from fetal calf serum-derived polyamines. The arg2
parasites were not able to proliferate as well as WT parasites in
medium without putrescine, reaching less than 1/10 of the WT
stationary cell concentration (Figure 4A). As expected, putrescine
medium supplementation with 10 to 50 mM led to equal growth
rescue of arg2 mutants (Figure 4B). Both the arg2/+ARG and arg2/
+argDSKL parasites grew similarly to WT parasites (Figure 4A).
Thus, despite the impairment of ARG in the arg2/+argDSKL
parasites, they were able to proliferate as well as WT and arg2/
+ARG parasites.
ARG mislocation or absence impairs L. amazonensis
infectivity
To determine the rates of macrophage infection 4, 24, 48 and
72 hours post-infection (Figure 5A) and the number of amastigotes
per infected macrophage as an indicator of amastigote prolifer-
ation capacity (Figure 5B), the infectivity of WT and mutant
parasites was first examined during in vitro infections of BALB/c
peritoneal macrophages. All strains presented a similar behavior at
4 hours post-infection, indicating that the initial phagocytosis was
not affected. After 24 hours post-infection, arg2 parasites had a
decreased macrophage infection rate compared with that of WT
parasites. arg2/+argDSKL parasites showed a similar impairment,
relative to WT, as the arg2 parasites (Figure 5A, striped bars). As
expected, arg2/+ARG presented a WT-like macrophage infection
rate and proliferation (Figure 5AB, gray bars). From 48 hours
post-infection, a decreased amastigote proliferation was observed
for arg2 and arg2/+argDSKL parasites (Figure 5B, white and
striped bars). From these data, the infectivity index (the rate of
infected macrophages multiplied by the average number of
amastigotes per infected cell) was calculated (Table 2). The
infectivity index of arg2 parasites was decreased by approximately
80% at 24 hours post-infection and 30% at 48 and 72 hours post-
infection, compared with the WT parasite. The recovery in arg2/
+ARG parasite infectivity indexes confirmed that the observed
decrease in the arg2 infectivity index was due to the lack of ARG.
Notably, arg2/+argDSKL parasites were unable to fully recover
Figure 2. L. amazonensis ARG protein level and enzymatic activity are impaired by arginase mislocation. (A) ARG mRNA copies were
determined by real time PCR and normalized by GAPDH mRNA copies for L. amazonensis wild type (WT), ARG knockout (arg2), and the add-backs
arg2/+ARG and arg2/+argDSKL strains. The obtained values are the means (+/2 SD) of at least 2 independent experiments each performed in
duplicate. The values for arg2/+ARG and arg2/+argDSKL are significantly different from those for arg2 and WT (p,0.0015*, t test). (B) ARG enzymatic
activity from protein extracts of the same strains was determined and is expressed as nmol/min/mg. The obtained values are the means (+/2 SD) of 3
independent experiments each performed in triplicate. The values for arg2/+ARG are significantly different from those for arg2 and arg2/+argDSKL
(p,0.0001**, t test). (C) ARG and Orc1 (loading control) levels were determined by western blotting of total cell lysates from the same strains before
and after treatment with MG-132 50 mM for 24 hours.
doi:10.1371/journal.pone.0034022.g002
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their infective capacity, presenting an infectivity index of
approximately 75% at 24 and 48 hours post-infection and 50%
at 72 hours, compared with WT parasites. These results indicate
that ARG absence or incorrect localization impairs parasite in vitro
infectivity.
The ability of the parasites to survive and induce lesions within
susceptible BALB/c mice was then examined after footpad
inoculation with 106 stationary phase promastigotes (Figure 6).
The arg2 parasites induced a delayed lesion development
compared with the WT parasites, consistent with the results of
arg2 mutants in other Leishmania species [13,14]. After 59 days, the
lesions induced by arg2 parasites were approximately 36% smaller
than those induced by WT parasites. Despite the substantial
restoration of ARG enzyme levels, ARG metabolism, and full
infectivity in vitro, the arg2/+ARG parasites only partially rescued
the progression of the infection. Notably, arg2/+argDSKL parasites
showed a greater delay in lesion formation than observed with the
arg2 mutant. After 59 days, lesions induced by the arg2/+argDSKL
parasites were approximately 76% smaller than those induced by
the WT parasites and 32% smaller than those induced by the arg2
parasites (p,0.0001, One-way ANOVA test). At this point, the
WT-infected mice were sacrificed. After 16 weeks, the mice
infected with the arg2/+argDSKL mutant presented lesions that
corresponded to approximately 60% of the ones induced by the
WT parasites (data not shown).
Taken together, these results show that restoring ARG
expression in its native sub-cellular location at least partially
recovers the infectivity of L. amazonensis arg2 parasites. The
presence of incorrectly located arginase (arg2/+argDSKL), howev-
er, did not improve the arg2 in vitro infectivity; instead, it resulted in
an even more substantial loss in infectivity.
Discussion
Previous studies have shown that Leishmania ARG is essential for
polyamine synthesis [11] and enhances parasite infectivity and
pathogenesis [13,14]. ARG compartmentalization in the glyco-
some, however, has been considered unimportant for proper
enzyme performance in L. mexicana physiology [11]. Here, we
show the importance of ARG glycosomal compartmentalization in
L. amazonensis, characterizing two add-back mutants: one with the
native ARG ORF (arg2/+ARG) and the other with a modified ARG
ORF lacking the C-terminal SKL glycosomal targeting sequence
(arg2/+argDSKL), which were generated from the initially
Figure 3. ARG cytosolic localization in arg2/+argDSKL add-back opposed to ARG glycosomal compartmentalization in WT and arg2/
+ARG add-back. Cytological preparations probed for ARG immunolocalization via electron microscopy of L. amazonensis wild type (WT), ARG
knockout (arg2), and the add-backs arg2/+ARG and arg2/+argDSKL promastigotes. Images are representative of at least 8 different sections. Black
arrows indicate membrane-surrounded organelles that present the same microscopic pattern as glycosomes. Parasite nuclei (N). Scale bar: 250 nm.
doi:10.1371/journal.pone.0034022.g003
Table 1. L-arginine cellular concentration is increased in arg2
and arg2/+argDSKL compared with WT and arg2/+ARG.
L-arginine cellular concentration (nmol/107
parasites)
WT 19.07 (0.43)
arg2 79.24 (25.86)*
arg2/+ARG 28.57 (14.18)1
arg2/+argDSKL 93.57 (27.20)*#
L-arginine cellular concentration in L. amazonensis wild type (WT), ARG
knockout (arg2) and the add-backs arg2/+ARG and arg2/+argDSKL, determined
by HPLC analyses of cellular extracts from 107 parasites. Values are the means
(+/2SD) of a representative experiment performed in triplicate.
*indicates values significantly different compared with WT (p,0.05, t test).
1 and #indicates values with no significant difference compared with WT and
arg2, respectively.
doi:10.1371/journal.pone.0034022.t001
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obtained L. amazonensis ARG null mutant (arg2) that did not express
ARG mRNA or present ARG activity. ARG mRNA expression was
only partially restored in both add-back mutants. Although the
ARG add-back sequences were integrated into the non-native SSU
rRNA locus, the partial rescue could be explained by the absence
of the ARG 59 and 39 UTR native regulatory sequences. In fact,
ARG mRNA half-life determination in both add-back mutants
revealed a diminished stability when compared with WT.
Figure 4. ARG absence impairs parasite growth in vitro. Growth curves of L. amazonensis wild type (WT), ARG knockout (arg2) and the add-
backs arg2/+ARG and arg2/+argDSKL promastigotes in the absence (A) or presence (B) of 10 mM (arg2 2), 30 mM (arg2 3) or 50 mM (WT, arg2, arg2/
+ARG and arg2/+argDSKL) putrescine. The obtained values are the means (+/2 SD) of one representative experiment performed in triplicate.
doi:10.1371/journal.pone.0034022.g004
Figure 5. ARG absence or improper sub-cellular location impairs L. amazonensis in vitro infectivity. Peritoneal macrophages infected with
L. amazonensis wild type (WT, white bars), ARG knockout (arg2, black bars) and the add-backs arg2/+ARG (grey bars) and arg2/+argDSKL (dashed
bars) mutants for 48 and 72 hours. (A) Means (+/2 SD) of the rate of macrophage infection from two experiments. (B) Means (+/2 SD) of amastigotes
per infected macrophage from two experiments. At least 150 macrophages were analyzed for each experiment. # indicates values with no significant
difference (One-way ANOVA). * p,0.005 and ** p,0.05 (t test).
doi:10.1371/journal.pone.0034022.g005
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The partial recovery in protein level and ARG enzymatic
activity of the arg2/+ARG add-back may result from the partial
expression of ARG mRNA. Interestingly, despite the partial ARG
mRNA expression recovery, the arg2/+argDSKL add-back showed
faint ARG labeling in western blot assays and no ARG enzyme
activity. At the EM level, however, ARG labeling confirmed the
cytosolic location of the enzyme in these add-backs.
Considering that improperly located ARG could impair
assembly of the trimer form of the active enzyme [15], we
assumed that the mistargeted ARG could be being degraded via
the proteasome pathway, which is widely known for its role in
cellular quality control against misfolded proteins present in the
cytosol [21–23]. Treatment with a trypanosome proteasome
inhibitor, MG-132 [24], led to ARG accumulation in the WT
and both add-backs parasites, enabling ARG detection in arg2/
+argDSKL western blot and confirming the cytosolic location of
ARG by confocal immunolabeling.
Regarding in vitro proliferation, the arg2 null mutant is
auxotrophic for polyamines, as previously shown for L. mexicana
and L. major [11,12]. Nevertheless, the arg2/+argDSKL axenic
promastigotes were able to grow without putrescine supplemen-
tation to the same levels achieved by both WT and arg2/+ARG
parasites. We conjectured that the minimal amount of ARG
detected via western blot and EM could lead to a level of ARG
activity not detectable by the used dosage method but sufficient for
the mutant to overcome the in vitro promastigote proliferation.
There was, however, a significant impairment of in vitro and in vivo
pathogenicity of the arg2/+argDSKL mutant. The in vivo infection
results point to an important role for the L. amazonensis ARG in
providing polyamines for amastigote proliferation in the host
environment. In addition, incorrectly located ARG ablates
parasite infectivity even more than its absence. This observation
was confirmed by in vitro macrophage infection, which showed a
reduced infectivity of the arg2/+argDSKL mutant at 24 hours post-
infection. The initial steps of in vitro infection (4 hours post-
infection) showed that the reduced infectivity was not due to the
capacity of the mutants to enter the host cell. These infection data
corroborate those reported for L. mexicana and L. major arg2
mutants [13].
L-arginine availability is known to be important for the balance
of the Th1/Th2 response in Leishmania infection [6,25]. The four-
fold increase in the L-arginine internal pool observed in arg2 and
arg2/+argDSKL mutants, associated with their impaired infectiv-
ity, could indicate that one of the roles of ARG during infection is
Table 2. ARG absence or improper sub-cellular location
impairs L. amazonensis in vitro infectivity.
Strain 4 h 24 h 48 h 72 h
WT 1.48 (0.27) 1.50 (0.23) 3.69 (0.70) 7.05 (0.64)
arg2 1.27 (0.11) 1.21 (0.05) 1.13 (0.64)* 2.20 (0.62)***
arg2/+ARG 1.46 (0.33) 1.92 (0.03) 4.94 (0.54) 13.03 (3.53)
arg2/+argDSKL 1.67 (0.25) 1.13 (0.30)** 2.91 (0.78)** 3.79 (1.20)**
Infectivity indexes (macrophage infection rate [Fig. 5A]6amastigotes/
macrophage means [Fig. 5B]) of peritoneal macrophages infected with L.
amazonensis wild type (WT), ARG knockout (arg2) and the add-backs arg2/
+ARG and arg2/+argDSKL after 4, 24, 48 or 72 hours. The standard deviation is
presented in brackets. Values are significantly different in relation to WT, with p-
values: p#0.01*, p = 0.007***; or in relation to arg2/+ARG: p,0.03** (t test).
doi:10.1371/journal.pone.0034022.t002
Figure 6. L. amazonensis in vivo infectivity is impaired by lack of ARG and incorrect location. BALB/c mice were infected in the posterior
left footpad with 106 stationary phase promastigotes cells of L. amazonensis wild type (WT), ARG knockout (arg2) and the add-backs arg2/+ARG and
arg2/+argDSKL parasites, and lesion sizes were monitored weekly. Data are presented as the means (+/2 SD) of 5 infected mice and are
representative of at least 2 different strains of null and add-backs mutants.* p,0.005 (Two-way ANOVA).
doi:10.1371/journal.pone.0034022.g006
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modulating the availability of L-arginine, and consequently
regulating the host immune response via the iNOS pathway
[8,9] or the MAPK pathway, which recently was indicated as
another L-arginine-dependent pathway [26]. In addition, modu-
lating L-arginine availability would also affect parasite infectivity
by influencing the NO production of the parasite [27].
Another participant in this complex balance is the host ARG
type I, which is also an important participant during parasite
pathology and would be affected by the parasite’s modulation of L-
arginine availability [28]. Indeed, further studies using the mutant
parasites described in this work demonstrated that the internal
pool of L-arginine is important in uptake regulation by modulating
the amino acid transporter expression. We previously showed that
the expression of the arginine transporter is modulated by arginase
activity [29].
To summarize, our results indicate the importance of parasite
ARG glycosomal localization for its role in the complex
equilibrium that defines L-arginine fate and optimizes parasite
infectivity. We speculate that the glycosome contains the optimal
L-arginine concentration for arginase optimal activity. Our results
differ from those of previous studies with L. mexicana, implying that
the ARG sub-cellular milieu is not essential for its role in
polyamine biosynthesis [11]. Other studies, however, have shown
that the compartmentalization of certain enzymes in the glyco-
some is essential, and even minor mislocations of glycosomal
enzymes, such as phosphoglycerate kinase (PGK), are lethal in the
bloodstream form of Trypanosome brucei [30–32]. In addition, it the
compartmentalization of glycolytic enzymes has long been known
to improve glycolysis energy production in trypanosomatids by
circumventing the low energy production (from the conversion of
glucose to pyruvate) that occurs during the mammal cycle phase
[33,34]. Additionally, glycolysis compartmentalization in the
glycosomes prevents the accumulation of toxic intermediates
generated during glucose degradation [35]. A recent study showed
that glycosomal localization of Leishmania major dihydroxyacetone-
phosphate acyltransferase is important for lipophosphoglycan
synthesis [36].
Together with previous studies, our work indicates that both
parasite and host ARGs are important for Leishmania infectivity.
Because of the high similarity between these two enzymes,
however, the screening of specific molecular inhibitors to target
the parasite ARG has not been so promising regarding the pursuit
of new leishmaniasis chemotherapies [37,38]. Considering the
location of ARG and its importance in modulating L-arginine
availability, we propose that studies regarding Leishmania protein
sorting mechanisms and L-arginine transport to the parasite
glycosome are fundamental for understanding parasite physiology
and for the screening of new drugs that would block protein
glycosome import or substrate transport to the parasite glycosome,
thereby compromising parasite survival in the host. This approach
should be promising in the pursuit of new leishmaniasis
chemotherapies.
Materials and Methods
Cell cultures
Leishmania amazonensis (MHOM/BR/1973/M2269) promasti-
gotes were maintained in culture at 25uC in M199 (Invitrogen,
Grand Island, NY, USA) supplemented with 10% (v/v) heat-
inactivated fetal bovine serum (FBS; Invitrogen) or 0.5% FBS for
growth experiments. J774A 1 macrophages were cultured at 37uC
in 5% CO2 in RPMI medium (Invitrogen) supplemented with
10% (v/v) heat-inactivated FBS.
Molecular constructs for the generation of arg2 null and
genetically supplemented mutants
For targeted gene replacement of L. amazonensis ARG, the 59
UTR-coding ARG flanking region was obtained by PCR using
oligonucleotides 1 and 2 (Table S1) and genomic DNA from L.
amazonensis as a template. The amplicon was cloned in pGEM-T
easy (Promega, Madison, WI, USA) and purified after digestion
with EcoRI and KpnI. The fragment was inserted into a similarly
digested pUC19 vector DNA. The 39 UTR-coding ARG flanking
region was obtained by PCR using oligonucleotides 3 and 4 (Table
S1) and genomic DNA from L. amazonensis as a template. The
amplicon was cloned in pGEM-T easy (Promega) and purified
after digestion with XbaI and PstI. The fragment was inserted into
the similarly digested 59 UTR-coding ARG containing pUC19
plasmid, yielding an intermediate, p5A3A, into which drug
markers could be inserted between the 59 and 39 UTR coding
ARG flanking regions.
The fragment containing the HYG ORF plus the 59 DHFR
region, encompassing expression regulating elements, was ob-
tained by PCR using oligonucleotides 5 and 6 (Table S1) and
pXGHYG DNA as a template. The amplicon was cloned into
pGEM-T easy (Promega). The recombinant plasmid was purified
and digested with KpnI and XbaI. The produced fragment was
inserted into the intermediate p5A3A, yielding the p5AHYG3A
construct (Fig. S1A). The same procedure was performed for the
PAC ORF using the pXGPAC DNA template, which yielded the
p5APAC3A construct (Fig. S1A).
Gene-targeting linear fragments, which were to be used in
transfection experiments, were obtained by PCR amplification
using p5AHYG3A or p5APAC3A plasmid DNA as templates with
oligonucleotides 7 and 8 (Table S1), which flank the region
containing the HYG/PAC cassette between the 59 and 39 ARG. For
replacement of the first ARG allele, 8 mg of purified fragment
containing the HYG cassette was transfected into L. amazonensis
using the high-voltage electroporation protocol described else-
where [39]. The transfectants were plated on semisolid medium
containing 30 mg/mL hygromycin B (Invitrogen). Several clones
were obtained, and the correct insertion was verified by PCR
analyses (Fig. S1B).
Several of the heterozygous replacements (ARG/Darg::HYG)
were subjected to a second transfection round with 8 mg of the
purified fragment containing the PAC cassette for replacement of
the second ARG allele. The transfectants were plated on semisolid
medium containing 30 mg/mL hygromycin B and 30 mg/mL
puromycin (Sigma, St. Louis, MO, USA), as well as 50 mM
putrescine (Sigma) to circumvent auxotrophy [12]. Numerous
clonal lines were obtained, and successful replacements of ARG
alleles were certified by PCR amplification analysis (Fig. S1B).
These Darg::HYG/Darg::PAC ARG knockout lines are referred to in
the text as arg2.
For genetic complementation of arg2 null parasites, the ARG
ORF with (ARG) and without the SKL glycosomal targeting signal
(argDSKL) were obtained by PCR amplification from L.
amazonensis genomic DNA using the oligonucleotide pairs 9/10
or 9/11 (Table S1), respectively. The amplicons were cloned into
pGEM-T easy (Promega). Plasmid DNA was digested with BamHI,
and the purified fragments were inserted into a similarly digested
pIR1PHLEO vector [40], yielding the pIR1_ARG and pIR1_-
argDSKL constructs, respectively (Fig. S2A).
To restore ARG expression in arg2 parasites, linear fragments
targeting for SSU rRNA insertion were obtained by digesting
pIR1_ARG and pIR1_argDSKL with SwaI, followed by dephos-
phorylation. A total of 8 mg of the purified fragments was
transfected into arg2 parasites using the same electroporation
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conditions as described above. The transfectants were plated on
semisolid medium containing 30 mg/mL hygromycin B, 30 mg/
mL puromycin, 50 mM putrescine and 20 mg/mL phleomycin
(Sigma). Several clonal lines were obtained, and correct insertion
was confirmed by PCR amplification analyses (Fig. S2B). These
add-back lines are referred to in the text as arg2/+ARG or arg2/
+argDSKL, respectively.
Reverse transcription and quantitative real-time PCR
RNA was obtained using TRIzolH Reagent (Invitrogen) or
RNeasyH Micro kit (Qiagen, Germantown, MD), following the
manufacturers’ instructions. cDNA was synthesized using 200 U
RevertAidTM Reverse Transcriptase (Fermentas Life Sciences,
Burlington, Ontario, Canada) with 20 nmol oligo dT or 10 mM
Random Hexamers (Applied Biosystems, Carlsbad, CA, USA) and
1 mg total RNA in a final volume of 13 mL. The RNA was
denatured at 70uC for 5 minutes and then cooled to 15uC; next,
4 mL of 56 Buffer and 2 mL of 10 mM dNTP were added. The
reaction was heated to 37uC for 5 minutes, and then 1 mL (200 U)
of Reverse Transcriptase was added to the reaction, followed by
incubation at 42uC for 60 minutes. The enzyme was inactivated at
75uC for 15 minutes, and the reaction was stored at 220uC. A
negative control containing all reaction components except the
enzyme was included and submitted to real-time PCR to exclude
the possibility of DNA contamination in the RNA samples.
For real-time PCR of the cDNA synthesized from total RNA
extracted with TRIzolH Reagent (Invitrogen), one-tenth of the
reverse transcription product was used as a template. For real-time
PCR of cDNA synthesized from total RNA extracted with
RNeasyH Micro kit (Qiagen), a one-thousandth dilution was used
as a template for mRNA quantification, or a one-hundred-
thousandth dilution was used for SSU rRNA quantification. The
reactions were performed with 0.2 mM of each corresponding
primer pair and SYBRH Green (Applied Biosystems) in a final
volume of 50 mL. For L. amazonensis ARG and GAPDH quantifi-
cation, the specific primers 21/22 and 23/24, respectively, were
used (Table S1); the PCR reaction consisted of 40 cycles of
30 seconds at 94uC, followed by 30 seconds at 61uC. For L.
amazonensis SSU rRNA quantification, the specific primers 25/26
were used (Table S1); the PCR reaction consisted of 50 cycles of
20 seconds at 94uC, followed by 50 seconds at 62uC. Quantifica-
tion of target gene expression was performed according to a
standard curve prepared from a ten-fold serial dilution of a
quantified and linearized plasmid containing the DNA segment to
be amplified.
Arginase activity assay
ARG activity was assayed by measuring urea production using
the QuantiChromTM Urea Assay Kit (DIUR-500) (BioAssay
Systems, Hayward, CA). Leishmania promastigote pellets (5–86107
cells) were washed twice with PBS and resuspended in 40 mL of
150 mM Tris-HCl pH 7.8 buffer containing 1 mM MnSO4 and
protease inhibitors (50 mg/mL ITS, 1 mM fenantroline, 2 mM
benzamidine, 1 mM phenylmethanesulfonylfluoride [PMSF] and
2.5% [v/v] protease inhibitor cocktail [Sigma]). The cells were
lysed by thermal shock (10 cycles of alternating freezing in liquid
nitrogen and defrosting in a 42uC water bath). The Leishmania total
protein extract obtained was clarified by centrifugation at
100006g for 10 minutes at 4uC prior to the quantification of
protein content by Bio-Rad Protein Assay (Bio-Rad Laboratories,
Hercules, CA). A total of 10 mg of protein extract was used for L-
arginine hydrolysis initiated by the addition of 50 mM glycine and
80 mM L-arginine (pH 9.6) in a final volume of 100 mL.
Incubation was performed at 37uC, and the reaction was stopped
by transferring 5 mL of the previous reaction to 200 mL of the
QuantiChromTM Urea Assay Kit working reagent. The samples
were incubated for 2 hours at room temperature in the dark, and
the urea formed was colorimetrically quantified at 450 nm.
Anti-L. amazonensis ARG polyclonal serum production
Purified recombinant arginase from L. amazonensis was obtained
as described previously [15]. Briefly, E. coli BL21(DE3)pLysS cells
containing pRSET-ARG were induced for recombinant ARG
expression with 1 mM IPTG at 37uC for 3 hours in the presence
of 10 mM MnSO4. Recombinant arginase was obtained by
submitting protein lysates of these cells to a purification process
consisting of immobilized metal affinity chromatography followed
by ionic exchange chromatography.
A New Zealand white rabbit was immunized by subcutaneous
injection with 2 mg of the purified L. amazonensis ARG for the
production of a polyclonal antiserum against L. amazonensis ARG.
Western blotting
Parasites treated with or without 50 mM MG-132 (Z-Leu-Leu-
Leu-al, Sigma), an inhibitor of proteasome activity, were collected
and suspended in 16 Laemmli loading buffer. Samples (56106
cells/lane) were boiled for 5 minutes, subjected to SDS/PAGE
and transferred to nitrocellulose membranes (Hybond-C, Amer-
sham Biosciences, Little Chalfont, Buckinghamshire, England).
The membranes were blocked with 5% non-fat dry milk in PBS
containing 0.1% of Tween-20 for 1 hour. Protein loading was
assessed with a rabbit anti-Orc1 polyclonal antibody [41] at a
dilution of 1:500. A rabbit anti-L. amazonensis ARG polyclonal
antibody was used at a dilution of 1:250. A peroxidase-conjugated
goat anti-rabbit IgG (Santa Cruz Biotechnology, Santa Cruz, CA,
USA) antibody was used at a dilution of 1:1000. Labeling was
revealed with hydrogen peroxide and 4-chloro-naphthol. Labeling
densitometry was performed using NIH ImageJ 1.44 software.
Confocal Immunofluorescence
WT and mutant cells were fixed in PBS/paraformaldehyde 4%
for 1 hour at room temperature. Fixed cells were spotted on
microscope slides and allowed to air dry for slide attachment.
Samples were subjected to a 5-minute treatment with PBS/Triton
1% for cell permeabilization, followed by blocking with PBS/BSA
1% for 1 hour. Then, the samples were sequentially incubated
with a rabbit anti-arginase antibody at a dilution of 1:2000 for
18 hours at 37uC and an anti-rabbit IgG Fitc-conjugated antibody
(Sigma) at a dilution of 1:800 for 2 hours at 37uC in the presence
of 3 mM DAPI (49,69-diamidino-2-phenylindole, Invitrogen), for
DNA-rich structure staining. All steps were followed by several
washes with PBS. The slides were mounted in Vectashield (Vector,
Burlingame, CA) to reduce bleaching. Samples were examined
with a Zeiss LSM 510 confocal laser microscope using Argon and
Enterprise excitation lasers (Carl Zeiss, Oberkochen, Germany).
Actinomycin and Sinefungin treatments
RNA half-life was determined using 10 mg/mL Actinomycin D
(Sigma) and 2 mg/mL Sinefungin (Sigma) as described previously
[20]. At different times, the parasites were collected, and the
treatments were stopped by the addition of RNeasyH Micro kit
RLT Lysis Buffer (Qiagen) for RNA extraction, cDNA synthesis
and real-time PCR analyses as previously described. Data
regression for one-phase exponential decay was performed using
GraphPad Prism 4.0 software (San Diego, CA, USA).
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Amino acids cellular concentration HPLC analyses
Parasites (16107) were frozen, homogenized with 80% ethanol
(Merck KGaA, Darmstadt, Germany) and concentrated in a
speed vac (45uC, 1 hour). The samples were resuspended in 2 mL
of water and centrifuged at 20,0006g for 2 minutes. The
supernatant was passed through a mini-column Sep-Pak C18
(Waters), previously conditioned with 35% methanol (v/v), and
sequentially eluted with 65% methanol (v/v). Aliquots of 100 mL
were derivatizated with 100 mL of OPA derivatization solution
(1 mL of 0.3 M OPA in methanol, 50 mL of mercaptoethanol
and 10 mL of 0.1 M borate buffer, pH 9.5) during the
10 seconds before injection. Amino acids in each sample were
analyzed by high-performance chromatography (HPLC) on a C18
column (Shimadzu Shim-pack CLC ODS). Solvent 1 (65%
methanol; Merck) and solvent 2 (50 mM sodium acetate, 50 mM
sodium phosphate, 1 mL acetic acid, 2% methanol and 2%
tetrahydrofuran, pH 7.5), used in the mobile phase, were
combined in the following gradient based on the percent of
solvent 2 (35–40% [0.01–18 min], 40–65% [18–24 min], 65–
68% [24–35 min] and 68–100% [35–45 min]) at a flow rate of
1 mL/min. Fluorescence excitation at 250 nm and emission at
480 nm were used for amino acid detection. The retention times
and the areas of the peaks were measured by comparison with
known quantities of standards amino acids: alanine, aspartic acid,
glutamic acid, asparagine, serine, arginine, glutamine, histidine,
aminobutiric acid, glycine, threonine, alanine, tyrosine, methio-
nine, tryptophan, valine, phenylalanine, isoleucine, leucine, lysine
and ornithine.
In vitro macrophage infections
Peritoneal murine macrophages were obtained from BALB/c
mice. The animals were sacrificed in a CO2 chamber, following
the recommendations of the Animal Experimentation Ethical
Committee. A total of 5 mL of PBS was injected into the
peritoneal cavity. The peritoneum was rocked gently several
times, and the buffer was aspirated. The aspirated cell
suspension was washed with PBS at 15006g for 10 minutes at
4uC, and then the cells were counted and resuspended in RPMI
1640 medium (Invitrogen) supplemented with 10% (v/v) heat-
inactivated FBS (Invitrogen). Cells (26105) were seeded into
each chamber of an 8-well glass chamber slide (Lab-Tek
Chamber Slide; Nunc, Naperville, IL) and incubated for
18 hours at 34uC in 5% CO2. Non-adherent cells were washed
away with fresh medium, and 106 stationary phase promasti-
gotes were added to each well. After 4 hours of incubation at
34uC in 5% CO2 non-phagocytized promastigotes were washed
away with fresh medium. A sample was fixed and stained with
Giemsa (Merck KGaA, Darmstadt, Germany). The remaining
infected macrophages were incubated for an additional 20, 44
or 68 hours. After each period, the samples were fixed and
stained as above. The infectivity indexes (rate of infected
macrophages multiplied by the average number of amastigotes
per macrophage) were calculated by randomly counting at least
150 macrophages per slide.
Mouse infection
The virulence of WT and mutant L. amazonensis was evaluated
after footpad inoculation of BALB/c mice. Groups were injected
subcutaneously into the posterior left footpad with 106 stationary
phase promastigotes. Infections were monitored weekly by
subtracting the thickness (analyzed with a caliper) of the injected
footpad from that of the control (right) footpad.
Electron Microscopy
The electron immunolocalization experiments were performed
at the Molecular Microbiology Imaging Facility of Washington
University School of Medicine (St. Louis, MO).
J774A 1 macrophages were infected in vitro as described above
for peritoneal macrophages. L. amazonensis promastigotes or the
infected macrophages were fixed in 4% paraformaldehyde/0.05%
glutaraldehyde (Polysciences Inc., Warrington, PA) in 100 mM
PIPES/0.5 mM MgCl2 (pH 7.2) for 1 hour at 4uC. The samples
were embedded in 10% gelatin and infiltrated with 2.3 M
sucrose/20% polyvinyl pyrrolidone in PIPES/MgCl2 overnight
at 4uC. The samples were trimmed, frozen in liquid nitrogen and
sectioned with a Leica Ultracut UCT cryo-ultramicrotome (Leica
Microsystems Inc., Bannockburn, IL). Anti-ARG polyclonal rabbit
serum was used as a probe and visualized using an 18-nm colloidal
gold-conjugated goat anti-rabbit antibody (Jackson ImmunoR-
esearch Laboratories, Inc., West Grove, PA). The sections were
washed in PIPES buffer, followed by a water rinse, and stained
with 0.3% uranyl acetate/2% methyl cellulose. The samples were
examined with a JEOL 1200EX transmission electron microscope
(JEOL USA Inc., Peabody, MA). All labeling experiments were
conducted in parallel with controls in which the primary antibody
was omitted. These controls were consistently negative.
Statistical analysis
Statistical significance was determined by Student’s t test or
ANOVA test using Graph Pad Prism Software (GraphPad
Software, Inc., La Jolla, CA, USA). The obtained p-values are
indicated throughout the results.
Supporting Information
Text S1 mRNA half-lives of both ARGs integrated into
SSU rRNA locus is less than WT.
(DOC)
Figure S1 Generation of L. amazonensis ARG-null
mutant (arg2). (A) Gene replacement strategy. The
5AHYG3A/5APAC3A targeting fragments are shown above the
ARG chromosomal locus. The arrows indicate the position of
oligonucleotides (Table S1) used for PCR confirmation of planned
insertions. The expected amplicons and their size in base pairs are
indicated by brackets. (B) Agarose gels of the obtained amplicons
from L. amazonensis wild type (WT), ARG heterozygous (+/2) and
two ARG knockout clone (arg2) genomic DNA templates with the
indicated pairs of primers.
(TIFF)
Figure S2 Generation of L. amazonensis complemented
lines bearing WT or a glycosomal targeting sequence
deleted ARG (argDSKL). (A) Insertion strategy into SSU rRNA
locus. The targeting fragments containing ARG or argDSKL
(without SKL), selection marker Phleo and flanking recombination
sequences are shown above the chromosomal SSU rRNA locus.
The arrows indicate the position of oligonucleotides (Table S1)
used for PCR confirmation of planned insertions. The expected
amplicons and their size in base pairs are indicated by brackets. (B)
Agarose gel showing the obtained amplicons from L. amazonensis
wild type (WT), ARG knockout (arg2) and the add-backs arg2/
+ARG and arg2/+argDSKL mutants genomic DNA templates with
the indicated pairs of primers.
(TIFF)
Figure S3 Half-lives of arg2/+ARG and arg2/+argDSKL
add-back parasites ARG mRNA are shorter than WT
ARGmRNA. Relative copy-numbers of ARG (A) and GAPDH (B)
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mRNA, normalized by SSU rRNA expression, of L. amazonensis
wild type (WT), ARG knockout (arg2), and the add-backs arg2/
+ARG and arg2/+argDSKL treated with actinomycin/sinefungin
for mRNA decay determination. The obtained values are the
means (+/2 SD) of 3 independent experiments in duplicate. The
black lines represent the exponential decay fitting with R2.0.98.
t1/2 indicates the half-lives determined for each decay curve.
(TIFF)
Figure S4 Proteasome inhibition with MG-132 causes
ARG accumulation. ARG and Orc1 (loading control) levels in
L. amazonensis wild type (WT, white bars), and the add-backs arg2/
+ARG (gray bars) and arg2/+argDSKL (dashed bars) were
determined by western blot after 0 to 24 hours of treatment with
MG-132 50 mM (Fig. 1C). (A) ARG quantification before MG-132
treatment. Values were normalized by Orc-1 quantification and
are the means (+/2 SD) of duplicates of a representative
experiment. (B) The increase in ARG/Orc-1 levels after 1, 4, 8
and 24 hours of treatment with MG-132. ARG/Orc-1 values for
each strain were normalized by ARG/Orc-1 level of the same
strain before treatment.
(TIFF)
Figure S5 Inhibition of proteasome activity leads to
ARG accumulation confirming cytosolic location in
arg2/+argDSKL cells. L. amazonensis wild type (WT), ARG
knockout (arg2), and the add-backs arg2/+ARG and arg2/
+argDSKL parasites were treated (+) or not (2) with 50 mM
MG-132 during 24 hours and then submitted to immunofluores-
cence assays to determine ARG sub-cellular localization. (A) Blue
labeling, nuclei staining with DAPI. (B) Green labeling, ARG
immunolabeling. (C) Phase contrast. (D) Merge of A, B and C.
Images are representative of at least 5 different fields. Scale bar:
2 mm.
(TIFF)
Table S1 Nucleotide sequences of primers used.
(DOCX)
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